Tag Archive for: Tim XU

Tim Xu discusses new data from Amplyx

Phase 2 data from Arix portfolio company Amplyx and why anti-infectives are especially important now during the pandemic.

How close are we to a COVID-19 cure? A biotech VC perspective

“A viable therapeutic would dramatically change the tone of the COVID-19 pandemic, giving hope and a path to eradicating the virus, saving lives and livelihoods.”